May 11, 2026

A stronger case for cutting retail catalogue complexity

Retailers can protect margin and reduce cost by cutting catalogue complexity and making every product earn its place...

China stocks climb as AI optimism and exports support investor demand

Chinese stocks rallied as AI optimism, stronger exports and renewed interest in technology shares lifted mainland markets...

AI-led gains put Asian markets back in focus

Asian stocks are rising on AI demand, while weaker currencies and higher oil prices add risk...

Chariot Positioned for Growth as Cavendish Highlights Angola and Renewables Opportunity

The latest research note from Cavendish has reiterated its Buy rating on Chariot Limited (LON:CHAR), highlighting what analyst James McCormack describes as a compelling combination of upstream oil and gas..

Emerging markets attract fresh interest as AI trade expands

Emerging markets are gaining investor interest as AI demand, attractive valuations and potential currency tailwinds support the case for selective exposure...

Copper supply pressure strengthens the investment case

Copper’s rise highlights a more constructive investor case, with supply pressure and strategic demand outweighing short-term spot market weakness...

FTSE 100 edges higher as selective gains support a cautious market

FTSE 100 edges higher as selective gains in airlines, telecoms and financials offset a cautious backdrop of rising oil prices and elevated gilt yields...

Corero targets rising demand For Layer 7 attack protection

Corero is positioning Layer 7 protection as a practical response to rising application-layer security risk across modern enterprises...

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking a 103.67% Potential Upside

Telix Pharmaceuticals Limited (TLX), a key player in the biotechnology sector, captures investor attention with its promising radiopharmaceutical developments. Headquartered in North Melbourne, Australia, the company is a commercial-stage biopharmaceutical..

Ionis Pharmaceuticals (IONS) Stock Analysis: A Biotech Pioneer with 33% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is a frontrunner in the biotechnology sector, renowned for its pioneering RNA-targeted medicines. With a market capitalization of $12.51 billion, Ionis has carved a niche..

Teleflex Incorporated (TFX) Stock Analysis: A Look at the Healthcare Innovator’s 7.97% Potential Upside

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector specializing in medical instruments and supplies, catches the eye of investors with a notable potential upside of 7.97%. With..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Strategic Hold in the Biotech Space with Steady Potential

Soleno Therapeutics, Inc. (SLNO) is making waves in the biotechnology industry as it focuses on developing treatments for rare diseases, with its lead product candidate being VYKAT XR, targeting Prader-Willi..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Analyzing a 33% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands out in the biotechnology sector with a significant market cap of $11.76 billion. This Pennsylvania-based company is at the forefront of developing therapeutics for..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 24.88% Potential Upside in the Biotech Sector

Roivant Sciences Ltd. (ROIV), a UK-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a strong focus on innovative medicines and technologies. As individual investors seek opportunities..

Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with 36% Potential Upside

In the dynamic world of healthcare and medical instruments, Stevanato Group S.p.A. (NYSE: STVN) stands out as a formidable player. With a market capitalization of $4.98 billion, this Italian company..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst a Robust Market Position

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector’s medical care facilities industry, presents an intriguing case for investors seeking exposure to the niche market of kidney dialysis services...

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings Signal Promising Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company, is rapidly gaining attention in the healthcare sector with its innovative genetic medicines. With a market capitalization of $9.01 billion, Krystal..

Viatris Inc. (VTRS) Stock Analysis: Exploring the Healthcare Giant’s Valuation and Dividend Yield

Viatris Inc. (VTRS), a substantial player in the healthcare sector, has piqued the interest of investors with its expansive reach and diverse product portfolio. With a market capitalization of $20..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: High Growth Potential with a 52.61% Upside

iRhythm Holdings, Inc. (NASDAQ: IRTC), a leader in the healthcare sector specializing in medical devices, is capturing investor attention with its impressive growth trajectory and significant upside potential. With a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Gem with 46.76% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a compelling player in the biotechnology sector, focusing on pioneering solutions for rare neuroendocrine diseases. With a market cap of $6.45 billion, this Boston-based..

Search

Funds

May 11, 2026

A stronger case for cutting retail catalogue complexity

Retailers can protect margin and reduce cost by cutting catalogue complexity and making every product earn its place...

China stocks climb as AI optimism and exports support investor demand

Chinese stocks rallied as AI optimism, stronger exports and renewed interest in technology shares lifted mainland markets...

AI-led gains put Asian markets back in focus

Asian stocks are rising on AI demand, while weaker currencies and higher oil prices add risk...

Emerging markets attract fresh interest as AI trade expands

Emerging markets are gaining investor interest as AI demand, attractive valuations and potential currency tailwinds support the case for selective exposure...

Copper supply pressure strengthens the investment case

Copper’s rise highlights a more constructive investor case, with supply pressure and strategic demand outweighing short-term spot market weakness...

FTSE 100 edges higher as selective gains support a cautious market

FTSE 100 edges higher as selective gains in airlines, telecoms and financials offset a cautious backdrop of rising oil prices and elevated gilt yields...

Corero targets rising demand For Layer 7 attack protection

Corero is positioning Layer 7 protection as a practical response to rising application-layer security risk across modern enterprises...
Search

Funds

May 11, 2026

FTSE 100

Funds